These manifestations were initially vesicular and blistering lesions that subsequently evolved to the destruction of elastin fibers leading to large areas of cutis laxa in both patients, a phenomenon also described in the APLAID patient with the p.Leu848Pro PLCG2 variant [8]. Here, ELN is linked to cutis laxa.